The role of gefitinib in the management of Asian patients with non-small cell lung cancer

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.17, Iss.3, 2008-03, pp. : 401-411

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gefitinib in non-small cell lung cancer

By Tamura Kenji Fukuoka Masahiro

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 6, 2005-06 ,pp. : 985-993

Informa Healthcare

Access to resources Recommend Favorite

Role of EGFR Monoclonal Antibodies in the Management of Non–small Cell Lung Cancer

Current Cancer Drug Targets, Vol. 15, Iss. 9, 2015-11 ,pp. : 792-802

Bentham Science Publishers

Access to resources Recommend Favorite

Spotlight on Gefitinib in Non-Small-Cell Lung Cancer

By Frampton James E. Easthope Stephanie E.

American Journal of PharmacoGenomics, Vol. 5, Iss. 2, 2005-01 ,pp. : 133-136

Adis International

Access to resources Recommend Favorite

Non–Small Cell Lung Cancer

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Gefitinib: A Review of its Use in the Management of Advanced Non-Small-Cell Lung Cancer

By James E. Frampton Stephanie E. Easthope

Drugs, Vol. 64, Iss. 21, 2004-01 ,pp. : 2475-2492

Adis International

Access to resources Recommend Favorite